Small Molecule LCDM and GV Oocyte

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

250 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-05-01

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Immature eggs obtained during the oocyte retrieval cycle are discarded as medical waste because they cannot complete fertilization, but each egg is important for people with poor clinical outcome. In vitro maturation (IVM) technique allows immature GV and MI eggs to mature in vitro, offering hope for this population to increase the clinical pregnancy rate in a single oocyte retrieval cycle. However, the clinical effectiveness of IVM clinical application is still very low, especially the utilization rate of GV eggs is extremely low. The cocktail of small molecules includes four chemical components of LCDM, which are related to cell proliferation, in vitro maturation of eggs, and protection of cells from oxidative stress. Our preliminary experiments confirmed that the addition of a certain concentration of LCDM in the culture medium can significantly improve the in vitro maturation rate and embryo utilization rate of immature GV eggs. In this study, LCDM immature oocyte culture system was used to carry out in vitro maturation culture of GV oocytes, and combined with oocyte activation technology to verify the clinical safety of LCDM in vitro culture system by observing the in vitro maturation rate, fertilization rate and embryo development results of GV oocytes, so as to provide laboratory data for clinical application of GV oocytes in special patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

In Vitro Maturation (IVM) of Human Oocytes

NCT01843569

Polycystic Ovarian Syndrome (PCOS) Patients Sensitive to Exogenous Gonadotropins Ovarian Hyper Stimulation Syndrome (OHSS)

WITHDRAWN NA

New Application of Sequential in Vitro Muturation System for Infertility Patients With Polycystic Ovary Syndrome

NCT03773263

Polycystic Ovary Syndrome Infertility

UNKNOWN PHASE3

Evaluation of Pregnancy Outcome with Usage of Drug-free In-vitro Activation of Follicles Ovary

NCT06769789

Infertility (IVF Patients) Infertile Females or Females with Ovarian Insufficiency

NOT_YET_RECRUITING NA

In Vitro Maturation of Human Eggs

NCT02516462

Infertility Reproductive Techniques, Assisted

UNKNOWN NA

Effects of Seminal Plasma on Pregnancy Rate With IVF

NCT02716753

Infertility

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Assisted Reproduction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

experimental group

In the experimental group, LCDM was added to the general mature culture medium.

Small molecule LCDM

Intervention Type OTHER

The cocktail of small molecules includes four chemical components of LCDM were added to GV oocyte culture medium.

control group

In the control group, he culture medium was general mature culture medium.

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.